Monarch Partners Asset Management LLC Evolus, Inc. Transaction History

Monarch Partners Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$10.22 - $13.94 $1.8 Million - $2.45 Million	-175,720 Reduced 68.43%	81,069 $940,000
Q1 2022 May 06, 2022	BUY	$5.22 - $11.78 $473,297 - $1.07 Million	90,670 Added 54.58%	256,789 $2.88 Million
Q4 2021 Feb 03, 2022	BUY	$5.37 - $8.38 $75,496 - $117,814	14,059 Added 9.25%	166,119 $1.08 Million
Q3 2021 Nov 04, 2021	SELL	$7.36 - $13.67 $20,240 - $37,592	-2,750 Reduced 1.78%	152,060 $1.16 Million
Q2 2021 Jul 30, 2021	BUY	$8.42 - $13.96 $1.3 Million - $2.16 Million	154,810 New	154,810 $1.96 Million

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monarch Partners Asset Management LLC with notifications on news.